Professor files complaint of scientific misconduct over allegation of ghostwriting
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4458 (Published 13 July 2011) Cite this as: BMJ 2011;343:d4458- Bob Roehr
- 1Washington, DC
A complaint of scientific misconduct has been filed with the US Office of Research Integrity regarding a ghostwritten paper on paroxetine (marketed as Paxil), published in 2001 in the American Journal of Psychiatry.
In the complaint Jay Amsterdam, a professor of psychiatry at the University of Pennsylvania and co-principal investigator of the paroxetine study 352 for bipolar depression, claims that he was “excluded from the final data review, analysis, and publication.”
Professor Amsterdam’s lawyer wrote in a letter to the university’s president, Amy Gutmann, “It is my client’s belief that the data from his study was effectively stolen from him, manipulated and used in a ghostwritten article . . . in order to advance a marketing scheme by GlaxoSmithKline to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.